Article info

Download PDFPDF
Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension

Authors

  1. Correspondence to Dr Gary D Novack, PharmaLogic Development, Inc., 17 Bridgegate Drive, San Rafael, CA 9490, USA; gary_novack{at}pharmalogic.com
View Full Text

Citation

Lewis RA, Levy B, Ramirez N, et al
Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension
Online issue publication 
February 19, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.